IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer

Radiotherapy and Oncology

Volumn 112, Issue 2, 2014, Pages 289-294

  Trip, Anouk Kirsten ^a   Nijkamp, Jasper ^a   Van Tinteren, Harm ^a   Cats, Annemieke ^a   Boot, Henk ^a   Jansen, Edwin Petrus Marianus ^a   Verheij, Marcel ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

3D conformal; AP PA; Gastric cancer; IMRT; Nephrotoxicity; Postoperative chemoradiotherapy

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; FOLINIC ACID; MERTIATIDE TC 99M; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE;

ADULT; AGED; ANTERIOR POSTERIOR POSTERIOR ANTERIOR RADIOTHERAPY; ARTICLE; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; RADIATION DOSE; RENOGRAPHY; STOMACH CANCER; THREE DIMENSIONAL RADIOTHERAPY; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; COMPUTER ASSISTED RADIOTHERAPY; DRUG EFFECTS; KIDNEY; KIDNEY DISEASES; MIDDLE AGED; PROCEDURES; RADIATION INJURIES; RADIATION RESPONSE; STOMACH NEOPLASMS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CISPLATIN; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; KIDNEY; KIDNEY DISEASES; LEUCOVORIN; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; STOMACH NEOPLASMS;

EID: 84910141323     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.08.039     Document Type: Article

References (27)

1. S.R. Smalley, J.K. Benedetti, D.G. Haller, S.A. Hundahl, N.C. Estes, and J.A. Ajani Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection J Clin Oncol 30 2012 2327 2333
2. T. Waddell, M. Verheij, W. Allum, D. Cunningham, A. Cervantes, and D. Arnold Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up Radiother Oncol 110 2014 189 194
3. J. Stiekema, A.K. Trip, E.P. Jansen, H. Boot, A. Cats, and O.B. Ponz The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy Ann Surg Oncol 21 2014 1107 1114
4. J.L. Dikken, E.P. Jansen, A. Cats, B. Bakker, H.H. Hartgrink, and E.M. Kranenbarg Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer J Clin Oncol 28 2010 2430 2436
5. J.L. Dikken, J.W. van Sandick, H.A. Maurits Swellengrebel, P.A. Lind, H. Putter, and E.P. Jansen Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS) BMC Cancer 11 2011 329
6. E.P. Jansen, J. Nijkamp, M. Gubanski, P.A. Lind, and M. Verheij Interobserver variation of clinical target volume delineation in gastric cancer Int J Radiat Oncol Biol Phys 77 2010 1166 1170
7. E.P. Jansen, H. Boot, R. Dubbelman, H. Bartelink, A. Cats, and M. Verheij Postoperative chemoradiotherapy in gastric cancer - a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy Br J Cancer 97 2007 712 716
8. M. Verheij, L.G. Dewit, R.A. Valdes Olmos, and L. Arisz Evidence for a renovascular component in hypertensive patients with late radiation nephropathy Int J Radiat Oncol Biol Phys 30 1994 677 683
9. L.A. Dawson, B.D. Kavanagh, A.C. Paulino, S.K. Das, M. Miften, and X.A. Li Radiation-associated kidney injury Int J Radiat Oncol Biol Phys 76 2010 108 115
10. K. de Cortie, N.S. Russell, R.P. Coppes, F.A. Stewart, and M. Scharpfenecker Bone marrow-derived macrophages incorporate into the endothelium and influence vascular and renal function after irradiation Int J Radiat Biol 2014 1 9
11. M. Scharpfenecker, B. Floot, N.S. Russell, and F.A. Stewart The TGF-beta co-receptor endoglin regulates macrophage infiltration and cytokine production in the irradiated mouse kidney Radiother Oncol 105 2012 313 320
12. M. Scharpfenecker, B. Floot, N.S. Russell, R.P. Coppes, and F.A. Stewart Thalidomide ameliorates inflammation and vascular injury but aggravates tubular damage in the irradiated mouse kidney Int J Radiat Oncol Biol Phys 89 2014 599 606
13. M. Scharpfenecker, B. Floot, N.S. Russell, R.P. Coppes, and F.A. Stewart Endoglin haploinsufficiency attenuates radiation-induced deterioration of kidney function in mice Radiother Oncol 108 2013 464 468
14. L. Dewit, M. Verheij, R.A. Valdes Olmos, and L. Arisz Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney Eur J Cancer 29A 1993 2239 2243
15. S. Kost, W. Dorr, K. Keinert, F.H. Glaser, G. Endert, and T. Herrmann Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy Int J Radiat Biol 78 2002 695 702
16. J. Boda-Heggemann, R.D. Hofheinz, C. Weiss, P. Mennemeyer, S.K. Mai, and P. Hermes Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer Int J Radiat Oncol Biol Phys 75 2009 1187 1195
17. A.Y. Minn, A. Hsu, T. La, P. Kunz, G.A. Fisher, and J.M. Ford Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer Cancer 116 2010 3943 3952
18. P. Wieland, B. Dobler, S. Mai, B. Hermann, U. Tiefenbacher, and V. Steil IMRT for postoperative treatment of gastric cancer: covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach Int J Radiat Oncol Biol Phys 59 2004 1236 1244
19. E.P. Jansen, H. Boot, M.P. Saunders, T.D. Crosby, R. Dubbelman, and H. Bartelink A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer Int J Radiat Oncol Biol Phys 69 2007 1424 1428
20. E.P. Jansen, H. Boot, R. Dubbelman, M. Verheij, and A. Cats Postoperative chemoradiotherapy in gastric cancer - a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy Ann Oncol 21 2010 530 534
21. J.S. MacDonald, S.R. Smalley, J. Benedetti, S.A. Hundahl, N.C. Estes, and G.N. Stemmermann Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
22. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
23. F.A. Stewart, Y. Oussoren, and H. Bartelink The influence of cisplatin on the response of mouse kidneys to multifraction irradiation Radiother Oncol 15 1989 93 102
24. S. Welz, T. Hehr, C. Kollmannsberger, C. Bokemeyer, C. Belka, and W. Budach Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer Int J Radiat Oncol Biol Phys 69 2007 1429 1435
25. D. Cunningham, W.H. Allum, S.P. Stenning, J.N. Thompson, C.J. van de Velde, and M. Nicolson Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
26. E.P. Jansen, J. Nijkamp, M. Gubanski, P.A. Lind, and M. Verheij Interobserver variation of clinical target volume delineation in gastric cancer Int J Radiat Oncol Biol Phys 77 2010 1166 1170
27. H.I. Yoon, J.S. Chang, J.S. Lim, S.H. Noh, W.J. Hyung, and J.Y. An Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation Radiother Oncol 108 2013 72 77